Liastuti Lies Dina, Nursakina Yosilia
Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Department of Cardiovascular, Harapan Kita National Heart Center, Jakarta, Indonesia.
Front Cardiovasc Med. 2025 Feb 24;12:1473544. doi: 10.3389/fcvm.2025.1473544. eCollection 2025.
Congenital heart disease (CHD) is a major contributor to morbidity and infant mortality and imposes the highest burden on global healthcare costs. Early diagnosis and prompt treatment of CHD contribute to enhanced neonatal outcomes and survival rates; however, there is a shortage of proficient examiners in remote regions. Artificial intelligence (AI)-powered ultrasound provides a potential solution to improve the diagnostic accuracy of fetal CHD screening.
A literature search was conducted across seven databases for systematic review. Articles were retrieved based on PRISMA Flow 2020 and inclusion and exclusion criteria. Eligible diagnostic data were further meta-analyzed, and the risk of bias was tested using Quality Assessment of Diagnostic Accuracy Studies-Artificial Intelligence.
A total of 374 studies were screened for eligibility, but only 9 studies were included. Most studies utilized deep learning models using either ultrasound or echocardiographic images. Overall, the AI models performed exceptionally well in accurately identifying normal and abnormal ultrasound images. A meta-analysis of these nine studies on CHD diagnosis resulted in a pooled sensitivity of 0.89 (0.81-0.94), a specificity of 0.91 (0.87-0.94), and an area under the curve of 0.952 using a random-effects model.
Although several limitations must be addressed before AI models can be implemented in clinical practice, AI has shown promising results in CHD diagnosis. Nevertheless, prospective studies with bigger datasets and more inclusive populations are needed to compare AI algorithms to conventional methods.
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023461738, PROSPERO (CRD42023461738).
先天性心脏病(CHD)是导致发病和婴儿死亡的主要原因,给全球医疗成本带来了最高负担。先天性心脏病的早期诊断和及时治疗有助于提高新生儿预后和存活率;然而,偏远地区缺乏熟练的检查人员。人工智能(AI)驱动的超声为提高胎儿先天性心脏病筛查的诊断准确性提供了一种潜在解决方案。
在七个数据库中进行文献检索以进行系统评价。根据PRISMA流程2020以及纳入和排除标准检索文章。对符合条件的诊断数据进行进一步的荟萃分析,并使用诊断准确性研究质量评估-人工智能测试偏倚风险。
共筛选出374项符合条件的研究,但仅纳入9项研究。大多数研究使用深度学习模型,利用超声或超声心动图图像。总体而言,人工智能模型在准确识别正常和异常超声图像方面表现出色。对这九项先天性心脏病诊断研究进行荟萃分析,采用随机效应模型得出合并敏感度为0.89(0.81 - 0.94),特异度为0.91(0.87 - 0.94),曲线下面积为0.952。
尽管在人工智能模型能够应用于临床实践之前必须解决一些限制,但人工智能在先天性心脏病诊断方面已显示出有前景的结果。然而,需要有更大数据集和更具包容性人群的前瞻性研究,以将人工智能算法与传统方法进行比较。
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023461738,PROSPERO(CRD42023461738)